TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Biobank AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13,930
|
14,537
|
12,921 |
Financial expenses |
28
|
31
|
33 |
Earnings before taxes |
1,932
|
371
|
932 |
Total assets |
14,911
|
14,479
|
14,901 |
Current assets |
13,051
|
12,082
|
12,181 |
Current liabilities |
2,199
|
2,496
|
2,614 |
Equity capital |
10,228
|
8,721
|
8,421 |
- share capital |
300
![]() |
300
![]() |
300 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.6%
|
60.2%
|
56.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.9%
|
2.6%
|
7.2% |
Return on assets (ROA) |
13.1%
|
2.8%
|
6.5% |
Current ratio |
593.5%
|
484.1%
|
466.0% |
Return on equity (ROE) |
18.9%
|
4.3%
|
11.1% |
Change turnover |
-607
|
1,616
|
-1,433 |
Change turnover % |
-4%
|
13%
|
-10% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.